Skip to main content

Infutraze Injectable Perfusion

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use INFUTRAZE CONCENTRATE FOR PERFUSION SOLUTION

Contents of the leaflet

  1. Introduction
  2. What is Infutraze and what is it used for
  3. What you need to know before you use Infutraze
  4. How to use Infutraze
  5. Possible side effects
  6. Storage of Infutraze
  7. Contents of the pack and other information

Introduction

Package Leaflet: Information for the Patient

Infutraze concentrated solution for infusion

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or nurse.
  • If your child experiences any side effects, talk to your doctor or nurse, even if you think they might be unrelated to this medicine. See section 4.

Contents of the Package Leaflet

  1. What is Infutraze and what is it used for
  2. What you need to know before you use Infutraze
  3. How to use Infutraze
  4. Possible side effects
  5. Storage of Infutraze
  6. Contents of the pack and other information

1. What is Infutraze and what is it used for

Infutraze is a mixture of trace elements administered into the blood by drip (intravenous perfusion). Infutraze contains five trace elements (zinc, copper, manganese, selenium, and iodine) in very small amounts that are normally absorbed from food. These trace elements are necessary for the normal functioning of the body.

Infutraze is used to cover the basic needs of trace elements in premature and full-term newborns, infants, children, and adolescents who cannot eat or absorb enough food through tube feeding and therefore need intravenous nutrition (so-called parenteral nutrition). Infutraze is added to parenteral nutrition containing all the nutrients the body needs.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Infutraze

Do not use Infutraze if your child:

  • is allergic to the active substances or to any of the other ingredients of this medicine (listed in section 6).
  • has Wilson's disease.

Warnings and precautions

Talk to your doctor before starting Infutraze if your child has:

  • kidney problems
  • liver problems
  • reduced bile excretion
  • thyroid problems (hyperthyroidism)

During treatment, your doctor will periodically check the levels of trace elements in the blood. Your doctor will adjust the dose of Infutraze accordingly.

Children and adolescents

Infutraze is indicated for premature and full-term newborns, infants, children, and adolescents.

Other medicines and Infutraze

Tell your doctor if your child is taking, has recently taken, or might take any other medicines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, talk to your doctor before using Infutraze.

Infutraze contains sodium and potassium

This medicine contains less than 23 mg of sodium (1 mmol) per 10 ml ampoule; this is essentially 'sodium-free'.

This medicine contains less than 39 mg (1 mmol) of potassium per 10 ml ampoule, which is considered essentially 'potassium-free'.

3. How to use Infutraze

Infutraze will be administered to your child in the form of intravenous perfusion (into the blood through a drip) by a healthcare professional. Infutraze will always be diluted in another parenteral nutrition solution.

Your doctor will decide on the individual dose for your child based on body weight and activity.

A daily infusion of iron is recommended when parenteral nutrition is administered for more than 3 weeks, and a perfusion of molybdenum should also be administered when parenteral nutrition is administered for more than 4 weeks.

If too much Infutraze is administered

It is unlikely that your child will receive too much Infutraze, as the perfusion will be controlled by a healthcare professional. If you think your child has received too much Infutraze, talk to your doctor.

If you have any other questions about the use of this medicine, ask your doctor or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

No side effects have been reported.

Reporting of side effects

If your child experiences any side effects, talk to your doctor, pharmacist, or nurse. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Infutraze

Keep this medicine out of the sight and reach of children.

Do not store above 25°C. Do not freeze.

Do not use this medicine if you notice visible signs of deterioration.

Do not use this medicine after the expiry date which is stated on the carton and on the label of the ampoule after EXP. The expiry date is the last day of the month shown.

Shelf-life after mixing

Stability after mixing has been demonstrated for a maximum of 7 days at 2-8°C followed by 48 hours at 20°C-25°C, including the duration of administration. From a microbiological point of view, the product should be used immediately. If not used immediately, the storage time and conditions before use are the responsibility of the user and normally should not exceed 24 hours at 2-8°C.

6. Contents of the pack and other information

Composition of Infutraze

The active substances are:

Infutraze

1 ml

1 ampoule (10 ml)

Zinc chloride

1042 micrograms

10420 micrograms

Copper(II) chloride dihydrate

107.4 micrograms

1074 micrograms

Manganese(II) chloride tetrahydrate

3.600 micrograms

36.00 micrograms

Sodium selenite

15.33 micrograms

153.3 micrograms

Potassium iodide

2.567 micrograms

25.67 micrograms

The active substances in 1 ml of Infutraze correspond to:

Zinc (Zn)

7.64 micromoles

500 micrograms

Copper (Cu)

0.630 micromoles

40.0 micrograms

Manganese (Mn)

0.0182 micromoles

1.00 microgram

Selenium (Se)

0.0887 micromoles

7.00 micrograms

Iodine (I)

0.0155 micromoles

1.96 micrograms

The other ingredients are

Hydrochloric acid (for pH adjustment)

Water for injections

Appearance of Infutraze and pack contents

Infutraze, concentrated solution for infusion, is a clear and almost colorless solution. It is presented in 10 ml transparent ampoules made of polypropylene.

Package sizes:

20 x 10 ml in a cardboard box

Marketing authorisation holder and manufacturer

Manufacturer:

HP Halden Pharma AS

Svinesundsveien 80

1788 Halden

Norway

Marketing authorisation holder:

Fresenius Kabi España, S.A.U.

Torre Mapfre-Vila Olímpica

C/Marina 16-18

08005 Barcelona

Spain

This medicine is authorised in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Austria

Kidtrayze Konzentrat zur Herstellung einer Infusionslösung

Belgium

Kidtrayze concentraat voor oplossing voor infusie

Kidtrayze solution à diluer pour perfusion

Kidtrayze Konzentrat zur Herstellung einer Infusionslösung

Bulgaria

????????? ????? ?????????? ?? ?????????? ???????

Peditrace Novum concentrate for solution for infusion

Croatia

Peditrace Novum koncentrat za otopinu za infuziju

Cyprus

Kidtrayze πυκν? δι?λυμα για παρασκευ? διαλ?ματος προς ?γχυση

Czech Republic

Peditrace Novum

Denmark

Peditrace Novum

Estonia

Infutraze

Finland

Kidtrayze

France

Peditrace solution à diluer pour perfusion

Germany

Kidtrayze Konzentrat zur Herstellung einer Infusionslösung

Greece

Kidtrayze πυκν? δι?λυμα για παρασκευ? διαλ?ματος προς ?γχυση

Hungary

Infutraze koncentrátum oldatos infúzióhoz

Iceland

Peditrace Novum

Italy

Kidtrayze

Ireland

Infutraze concentrate for solution for infusion

Latvia

Infutraze koncentrats infuziju šķīduma pagatavošanai

Lithuania

Infutraze koncentratas infuziniam tirpalui

Luxembourg

Kidtrayze

Malta

Kidtrayze

Netherlands

Kidtrayze concentraat voor oplossing voor infusie

Norway

Kidtrayze

Poland

Peditrace Novum

Portugal

Kidtrayze

Romania

Kidtrayze concentrat pentru solutie perfuzabila

Slovakia

Peditrace

Slovenia

KIDTRAYZE koncentrat za raztopino za infundiranje

Spain

Infutraze

Sweden

Peditrace Novum

United Kingdom

(Northern Ireland)

Infutraze concentrate for solution for infusion

Date of last revision of this leaflet:October 2023

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

<----------------------------------------------------------------------------------------------------------------->

This information is intended only for healthcare professionals:

Special warnings and precautions for use

Infutraze should be used with caution in patients with renal dysfunction, in whom the excretion of selenium, zinc, and iodine may be significantly decreased. There is a higher risk of accumulation of trace elements in these patients.

Infutraze should be used with caution in patients with hepatic dysfunction (especially cholestasis) in whom the excretion of copper and manganese may be decreased.

In patients with altered bile excretion, the elimination of manganese, copper, and zinc may be reduced. Clinical signs of accumulation of trace elements may require a reduction in the dose or discontinuation of Infutraze in these patients.

Dose adjustment may be necessary in patients with renal dysfunction and hepatic dysfunction or mild cholestasis.

Infutraze should be used with caution in patients with hyperthyroidism. In these patients, iodine may increase the symptoms of hyperthyroidism (e.g., goiter).

No dose adjustment of Infutraze is necessary in case of additional iodine intake through iodized antiseptics.

Long-term parenteral nutrition

In patients receiving long-term parenteral nutrition, accumulation of trace elements may occur, especially manganese. If treatment is prolonged for more than 4 weeks, manganese levels should be monitored. The appearance of neurological signs (e.g., anxiety, rapid eye movements) may indicate possible manganese overload, which may also be derived from certain medical conditions and parenteral nutrition. Manganese accumulation may require a reduction in the dose or discontinuation of Infutraze.

In patients receiving long-term parenteral nutrition, a deficiency of trace elements may occur, especially copper, zinc, and selenium. In case of deficiency, these individual trace elements should be supplied separately.

Posology

Preterm neonates:

A maximum recommended daily dose of 1.0 ml of Infutraze per kg of body weight covers the basic needs of the included trace elements.

Full-term neonates, infants, and children weighing less than 20 kg:

A maximum recommended daily dose of 0.5 ml of Infutraze per kg of body weight covers the basic needs of the included trace elements.

Children weighing more than 20 kg and adolescents:

A maximum recommended daily dose of 10 ml of Infutraze covers the basic needs of the included trace elements.

The following amounts of trace elements are contained in 0.5 ml, 1.0 ml, and 10 ml of Infutraze:

0.5 ml

1.0 ml

10 ml

Zn

250 micrograms

500 micrograms

5000 micrograms

Cu

20.0 micrograms

40.0 micrograms

400 micrograms

Mn

0.50 micrograms

1.00 micrograms

10.0 micrograms

Se

3.50 micrograms

7.00 micrograms

70.0 micrograms

I

0.98 micrograms

1.96 micrograms

19.6 micrograms

In addition to the trace elements contained in Infutraze, daily infusions of iron are recommended if patients receive parenteral nutrition for more than 3 weeks. A perfusion of molybdenum should also be administered if patients receive parenteral nutrition for more than 4 weeks.

Method of administration

Infutraze must not be administered undiluted. Infutraze will be administered in intravenous perfusion, diluted in a parenteral nutrition solution/emulsion. The speed and duration of the perfusion are determined by the speed and duration of the perfusion of the parenteral nutrition solution.

Infutraze can only be mixed with other nutritional products whose compatibility has been documented, see the Compatibility section below.

Special precautions for disposal and other handling

Before use, check visually that the concentrated solution for infusion is transparent and free of particles.

Compatibility

Dilute before use.

Infutraze is used as an additive for parenteral nutrition mixtures when compatibility data are available.

Compatibility data are available for the following products: Aminoven Infant, Vaminolact, Vamin 14, Vamin 18, Smoflipid, Intralipid, Vitalipid adult, Vitalipid infant, Soluvit N, Addiphos, and Glycophos in defined quantities, combined with generic glucose and electrolytes in defined quantities. Infutraze can also be added to SmofKabiven and SmofKabiven EF with or without Vitalipid N Infant/Adult and Soluvit N and electrolytes. The generated data support the additions according to the following summary table:

Infutraze

Mixture

0-10 ml/l

Aqueous PN mixtures with the components listed above.

0-10 ml/l

PN mixtures containing lipids with the components listed above

0-10 ml

SmofKabiven and SmofKabiven EF (activated bag of 986 ml, 1477 ml, 1970 ml, or 2463 ml) with electrolytes and vitamins as indicated above

0-5 ml

SmofKabiven and SmofKabiven EF (activated bag of 493 ml) with electrolytes and vitamins as indicated above

Infutraze should never be added directly to a lipid emulsion due to its destabilizing effects. It is recommended to mix the macronutrients (amino acid solution and glucose with or without lipid emulsion) before adding the micronutrients. Additions should be made aseptically.

The disposal of unused medicine and all materials that have been in contact with it should be done in accordance with local regulations.

Shelf-life after mixing

Stability after mixing (see Compatibility section) has been demonstrated for a maximum of 7 days at 2-8°C followed by 48 hours at 20°C-25°C, including the duration of administration. From a microbiological point of view, the product should be used immediately. If not used immediately, the storage time and conditions before use are the responsibility of the user and normally should not exceed 24 hours at 2-8°C.

Online doctors for INFUTRAZE CONCENTRATE FOR PERFUSION SOLUTION

Discuss questions about INFUTRAZE CONCENTRATE FOR PERFUSION SOLUTION, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor
5.0(1)

Cristina Andrada Brazo

General medicineSleep medicine16 years of experience
Licence no. 264505958

Dr. Cristina Andrada Brazo is a highly experienced Spanish physician with more than 15 years of clinical practice in emergency medicine, urgent care, and clinical neurophysiology. She provides professional online medical consultations for patients across Spain, helping both residents and international visitors receive timely medical advice, diagnosis, treatment recommendations, and electronic prescriptions when clinically appropriate.

As a licensed physician fully integrated with the Spanish electronic prescription system, Dr. Andrada can issue legally valid e-prescriptions following a medical assessment during an online consultation. Whether you need help with an acute illness, prescription renewal, neurological symptoms, or travel-related healthcare, she offers convenient, patient-centered medical care without the need to visit a clinic.

Dr. Andrada combines extensive emergency medicine experience with advanced expertise in neurology, epilepsy, sleep medicine, and headache disorders. Her international clinical background includes several years working in Switzerland, where she collaborated with multidisciplinary teams in emergency departments and neurology services. This experience strengthened her commitment to evidence-based medicine, compassionate communication, and high-quality patient care.

She graduated in Medicine from the University of Seville and completed her residency in Clinical Neurophysiology at Hospital Virgen de la Salud and the National Hospital for Paraplegics in Toledo. She currently works as a Clinical Neurophysiology Specialist at Hospital San Pedro in Logroño.

To further expand her expertise, Dr. Andrada completed several postgraduate qualifications, including Master's degrees in Sleep Physiology and Medicine, Medical Professionalism and Clinical Practice, Epilepsy, and Clinical Management.

Patients appreciate her thorough consultations, practical treatment recommendations, and empathetic approach. She speaks Spanish, French, and Portuguese, allowing her to communicate comfortably with patients from different backgrounds.

Conditions Dr. Cristina Andrada Treats Online

Dr. Andrada provides online consultations for a wide range of common medical conditions, including:

  • Fever, flu, COVID-19 symptoms, sore throat and respiratory infections
  • Sinusitis, bronchitis, cough and seasonal allergies
  • Urinary tract infections (UTIs)
  • Migraine and tension headaches
  • Dizziness and vertigo
  • Epilepsy and seizure follow-up
  • Sleep disorders, including insomnia and circadian rhythm disturbances
  • Heartburn, gastritis, diarrhea and constipation
  • Back pain, muscle injuries and joint pain
  • Minor skin infections and allergic reactions
  • Fatigue and general medical assessment
  • Prescription renewals for appropriate chronic treatments
  • Follow-up consultations after surgery or previous medical treatment
  • Travel medicine advice and preventive healthcare
  • Interpretation of laboratory results and medical reports

If your condition requires urgent in-person assessment or emergency care, Dr. Andrada will advise you on the most appropriate next steps.

Book an Online Consultation

Book a secure online consultation with Dr. Cristina Andrada Brazo through Oladoctor and receive professional medical advice from an experienced Spanish physician without leaving home. Online appointments are available for adults throughout Spain, with fast access to medical care and electronic prescriptions whenever clinically indicated.

Book a video appointment
€56
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

INFUTRAZE CONCENTRATE FOR PERFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in INFUTRAZE CONCENTRATE FOR PERFUSION SOLUTION is electrolytes in combination with other drugs. This information helps identify medicines with the same composition but different brand names.

INFUTRAZE CONCENTRATE FOR PERFUSION SOLUTION is manufactured by Fresenius Kabi España, S.A.U.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Cardiologists, Nephrologists, Hematologists, General surgeons, General medicine doctors, Phlebologists may assess whether INFUTRAZE CONCENTRATE FOR PERFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, INFUTRAZE CONCENTRATE FOR PERFUSION SOLUTION is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (electrolytes in combination with other drugs) include SUPLIVEN CONCENTRADO FOR PERFUSION SOLUTION, POTASSIUM ACETATE B.BRAUN 1 mEq/ml CONCENTRATE FOR INFUSION SOLUTION, SODIUM BICARBONATE 1/6 M MEIN SOLUTION FOR INFUSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media